Many of these clinics specialize in GLP-1 therapy and can offer more personalized monitoring than a general practice
Published in the New England Journal of Medicine in 2023, this phase 2 trial of retatrutide enrolled 338 adults with obesity
other cannabinoids except CBD are prohibited without exception
If the panel approves the request, people who experienced a type of vision loss called NAION after taking Zepbound will have new legal options for compensation
You must consult with a licensed, registered healthcare provider who can evaluate your medical history, BMI, and overall health to determine if you are a safe candidate
However, it is not classified as a food, drug, or dietary supplement and should not be used without professional guidance